Comparison of Hypertrophic Cardiomyopathy Candidate Gene Homologs in Human and Rhesus Macaque Sudden Cardiac Death Victims

Overview

About this study

This study is designed to identify genes shared between humans with hypertrophic cardiomyopathy and rhesus macaque primates who have experienced sudden cardiac death.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 or older
Have a diagnosis of HCM confirmed by transthoracic echocardiography
Have survived sudden cardiac death, or:
Received an appropriate shock after implantation of an implantable cardiac defibrillator (ICD) for primary prevention
Noted to have sustained VT on device interrogation

Exclusion Criteria:

Diagnosis of HCM is uncertain

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Komandoor Srivathsan, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Komandoor Srivathsan, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials